Rong Yang - Concepedia

Author

Rong Yang

Bristol-Myers Squibb (United States)ORCID

Also Known As

Ping-Ping Yang, Rong-De Ma1, Xue Zhao and Rui-Liang Zhu*, R Yang, R. YANG, R. Yang, R.‐Y. Yang, Rong Ya Yang, Rong Yang, Rong-Ya Yang, Rong-ya YANG, Rong-ya Yang

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)The Military General Hospital of Beijing PLA Texas Liver Institute The University of Texas Health Science Center at San Antonio Université Paris Cité

About

Rong Yang is an author at Bristol-Myers Squibb (United States) specializing in medicine, immunology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	976
2	Health Sciences	2	2	28
3	Natural Sciences	1	1	27
4	Biochemistry	1	1	27
5	Biology	1	1	20

Rong Yang

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study Jean‐Michel Molina, Jaime Andrade‐Villanueva, Juan Echevarría, The Lancet Treatment And PreventionAntiviral Drug DevelopmentClinical TrialsAntiviral TherapyVirology	2008	482
Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post‐liver transplantation recurrence Fred Poordad, Eugene R. Schiff, John M. Vierling, Hepatology	2016	456
Once-Daily Atazanavir/Ritonavir Compared With Twice-Daily Lopinavir/Ritonavir, Each in Combination With Tenofovir and Emtricitabine, for Management of Antiretroviral-Naive HIV-1–Infected Patients: 96-Week Efficacy and Safety Results of the CASTLE Study Jean‐Michel Molina, Jaime Andrade‐Villanueva, Juan Echevarría, JAIDS Journal of Acquired Immune Deficiency Syndromes	2010	253
Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC Cheng Quan, Yunqing Ren, Leihong Xiang, Nature Genetics Genome-wide Association StudyDisease SusceptibilityMedicineGeneticsPathogenesis	2010	216
Prevalence and Clinical Significance of HIV Drug Resistance Mutations by Ultra-Deep Sequencing in Antiretroviral-Naïve Subjects in the CASTLE Study Max Lataillade, Jennifer Chiarella, Rong Yang, PLoS ONE	2010	130
Daclatasvir in Combination With Asunaprevir and Beclabuvir for Hepatitis C Virus Genotype 1 Infection With Compensated Cirrhosis Andrew J. Muir, Fred Poordad, Jacob Lalezari, JAMA	2015	126
LO8 : Daclatasvir, sofosbuvir, and ribavirin combination for HCV patients with advanced cirrhosis or posttransplant recurrence: Phase 3 ALLY-1 study Fred Poordad, Eugene R. Schiff, John M. Vierling, Journal of Hepatology Ally-1 StudyHcv PatientsHepatologyViral HepatitisAntiviral Therapy	2015	94
Intestinal tract is an important organ for lowering serum uric acid in rats Yun Yu, Hua Yin, Zhiyi Gao, PLoS ONE	2017	91
A Nucleoside- and Ritonavir-Sparing Regimen Containing Atazanavir Plus Raltegravir in Antiretroviral Treatment-Naïve HIV-Infected Patients: SPARTAN Study Results Michael J. Kozal, Sergio Lupo, Edwin DeJesus, HIV Clinical Trials	2012	85
Randomized trial of three phototherapy methods for the treatment of acne vulgaris in <scp>C</scp>hinese patients Li‐Hong Liu, Xin Fan, Yuxi An, Photodermatology Photoimmunology & Photomedicine	2013	47

Page 1